INSP - Investigation Alert: Cummins Apellis Pharmaceuticals Inspire Medical and Applied Digital - Johnson Fistel LLP Encourages Long-Term Investors to Submit Their Information Below | Benzinga
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) --
Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of Cummins Inc. (NYSE:CMI), Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Inspire Medical Systems, Inc. (NYSE:INSP), and Applied Digital Corporation (NASDAQ:APLD).
Cummins Inc. (NYSE:CMI)
Johnson Fistel, LLP is investigating potential claims on behalf of Cummins, Inc. against certain of its officers and directors.
If you are a current, long-term shareholder of Cummins, you can click or copy and paste the link below in a browser to join this action:
https://www.cognitoforms.com/JohnsonFistel/CumminsInc
On December 22, 2023, Cummins reached an agreement with the U.S. Department of Justice, the U.S. Environmental Protection Agency (EPA), and the State of California to settle allegations related to emissions violations. The company agreed to pay a substantial $1.675 billion civil penalty for its actions.
California Attorney General Rob Bonta emphasized that Cummins knowingly evaded state emissions tests and requirements, causing harm to public health and the environment. This penalty represents the largest amount ever recovered by the DOJ under the Clean Air Act and is the second-largest environmental penalty secured.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Johnson Fistel LLP is investigating potential claims on behalf of Apellis Pharmaceuticals against certain of its officers and directors.
If you have continuously owned Apellis Pharmaceuticals shares since before January 28, 2021, submit your information below:
https://www.cognitoforms.com/JohnsonFistel/ApellisPharmaceuticalsInc2
Recently a class action lawsuit was filed against the company. According to the complaint, during the class ...